Systemic polyarteritis nodosa following hepatitis B vaccination

Area of Science:

• Immunology
• Rheumatology
• Vaccinology

Background:

• Hepatitis B vaccination is a crucial public health intervention.
• Autoimmune conditions, particularly vasculitis, have been anecdotally linked to vaccinations.
• Understanding vaccine-associated autoimmune risks is essential for patient safety.

Observation:

• A 14-year-old boy developed systemic polyarteritis nodosa (PAN) with symptoms including livedo reticularis, fever, and pain two months post-hepatitis B vaccination.
• The patient presented with elevated inflammatory markers (erythrocyte sedimentation rate and C-reactive protein).
• Diagnostic criteria for PAN were met, indicating a severe systemic inflammatory condition.

Findings:

• The patient's PAN diagnosis occurred two months after the third dose of the hepatitis B vaccine.
• A review of 27 reported cases suggests a potential link between hepatitis B vaccination and vasculitis.
• The authors propose vaccination as a possible trigger for vasculitis in susceptible individuals with genetic predisposition.

Implications:

• Physicians should consider the potential association between hepatitis B vaccination and the onset of vasculitis.
• This association may be more prevalent in individuals with underlying genetic susceptibility.
• Further research is warranted to elucidate the mechanisms and confirm the causal relationship between hepatitis B vaccination and autoimmune vasculitis.